# A Study of Vedolizumab in Adults With Crohn's Disease (CD)

> **NCT05192863** · — · COMPLETED · sponsor: **Takeda** · enrollment: 72 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05192863
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-20
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05192863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05192863, "A Study of Vedolizumab in Adults With Crohn's Disease (CD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05192863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*